These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 28825870

  • 1. Intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus.
    Garg R, Latimer L, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Hum Vaccin Immunother; 2017 Dec 02; 13(12):2894-2901. PubMed ID: 28825870
    [Abstract] [Full Text] [Related]

  • 2. Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunity.
    Garg R, Latimer L, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    J Gen Virol; 2014 May 02; 95(Pt 5):1043-1054. PubMed ID: 24572813
    [Abstract] [Full Text] [Related]

  • 3. Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation.
    Garg R, Latimer L, Simko E, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    J Gen Virol; 2014 Feb 02; 95(Pt 2):301-306. PubMed ID: 24136365
    [Abstract] [Full Text] [Related]

  • 4. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
    Sarkar I, Garg R, van Drunen Littel-van den Hurk S.
    Vaccine; 2016 Sep 30; 34(42):5114-5124. PubMed ID: 27591951
    [Abstract] [Full Text] [Related]

  • 5. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
    Garg R, Brownlie R, Latimer L, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Antiviral Res; 2018 Oct 30; 158():78-87. PubMed ID: 30071204
    [Abstract] [Full Text] [Related]

  • 6. Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles.
    Garlapati S, Garg R, Brownlie R, Latimer L, Simko E, Hancock RE, Babiuk LA, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Vaccine; 2012 Jul 27; 30(35):5206-14. PubMed ID: 22713718
    [Abstract] [Full Text] [Related]

  • 7. The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.
    Garg R, Latimer L, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Vaccine; 2015 Mar 10; 33(11):1338-44. PubMed ID: 25637860
    [Abstract] [Full Text] [Related]

  • 8. A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus.
    Garg R, Theaker M, Martinez EC, van Drunen Littel-van den Hurk S.
    Virology; 2016 Dec 10; 499():288-297. PubMed ID: 27721128
    [Abstract] [Full Text] [Related]

  • 9. Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs.
    Garg R, Latimer L, Wang Y, Simko E, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Vaccine; 2016 Jan 04; 34(2):261-269. PubMed ID: 26616551
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intranasal immunization with a helper-dependent adenoviral vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu YH, He JS, Qiao W, Jiao YY, Hua Y, Zhang Y, Peng XL, Hong T.
    Virol J; 2013 Jun 07; 10():183. PubMed ID: 23742026
    [Abstract] [Full Text] [Related]

  • 12. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH, Lee YT, Hwang HS, Kwon YM, Kim MC, Ko EJ, Lee JS, Lee Y, Kang SM.
    J Virol; 2015 Nov 07; 89(22):11692-705. PubMed ID: 26355098
    [Abstract] [Full Text] [Related]

  • 13. The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages.
    Sarkar I, Garg R, van Drunen Littel-van den Hurk S.
    Vaccine; 2018 Apr 19; 36(17):2326-2336. PubMed ID: 29559168
    [Abstract] [Full Text] [Related]

  • 14. Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.
    Passmore C, Makidon PE, O'Konek JJ, Zahn JA, Pannu J, Hamouda T, Bitko V, Myc A, Lukacs NW, Fattom A, Baker JR.
    Hum Vaccin Immunother; 2014 Apr 19; 10(3):615-22. PubMed ID: 24326268
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V, Boigard H, Bhatia B, Fallon JT, Alimova A, Gottlieb P, Galarza JM.
    Clin Vaccine Immunol; 2016 Jun 19; 23(6):451-9. PubMed ID: 27030590
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs.
    Garg R, Latimer L, Gomis S, Gerdts V, Potter A, van Drunen Littel-van den Hurk S.
    Antiviral Res; 2019 Feb 19; 162():54-60. PubMed ID: 30550799
    [Abstract] [Full Text] [Related]

  • 20. A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.
    Lee Y, Ko EJ, Kim KH, Lee YT, Hwang HS, Kwon YM, Graham BS, Kang SM.
    Virology; 2019 Aug 19; 534():1-13. PubMed ID: 31163351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.